The Motley Fool··Jonathan PoncianoANI Pharma Revenue Surges 44% to $883M; Insider Sale Signals Confidence
ANI Pharma posts record $883M revenue (up 44% YoY) with rare disease growth driving performance; insider sells 4,772 shares amid $1B+ 2026 guidance.
ANIPearnings guidancerevenue growth